110 related articles for article (PubMed ID: 19751414)
1. Antigenic phenotype and phagocytic capacity of MG-63 osteosarcoma line.
Díaz-Rodríguez L; García-Martínez O; Arroyo-Morales M; Reyes-Botella C; Ruiz C
Ann N Y Acad Sci; 2009 Sep; 1173 Suppl 1():E46-54. PubMed ID: 19751414
[TBL] [Abstract][Full Text] [Related]
2. Antigenic profile of osteoblasts present in human bone tissue sections.
García-Martínez O; Reyes-Botella C; Aguilera-Castillo O; Vallecillo-Capilla MF; Ruiz C
Biosci Rep; 2006 Feb; 26(1):39-43. PubMed ID: 16779666
[TBL] [Abstract][Full Text] [Related]
3. Antigenic phenotype of cultured human osteoblast-like cells.
Reyes-Botella C; Montes MJ; Vallecillo-Capilla MF; Olivares EG; Ruiz C
Cell Physiol Biochem; 2002; 12(5-6):359-64. PubMed ID: 12438772
[TBL] [Abstract][Full Text] [Related]
4. Effect of ibuprofen on proliferation, differentiation, antigenic expression, and phagocytic capacity of osteoblasts.
Díaz-Rodríguez L; García-Martínez O; De Luna-Bertos E; Ramos-Torrecillas J; Ruiz C
J Bone Miner Metab; 2012 Sep; 30(5):554-60. PubMed ID: 22543821
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact and immunogenicity of a novel osteosarcoma antigen, papillomavirus binding factor, in patients with osteosarcoma.
Tsukahara T; Kawaguchi S; Torigoe T; Kimura S; Murase M; Ichimiya S; Wada T; Kaya M; Nagoya S; Ishii T; Tatezaki S; Yamashita T; Sato N
Cancer Sci; 2008 Feb; 99(2):368-75. PubMed ID: 18271936
[TBL] [Abstract][Full Text] [Related]
6. Effect of platelet-rich plasma on growth and antigenic profile of human osteoblasts and its clinical impact.
García-Martínez O; Reyes-Botella C; Díaz-Rodríguez L; De Luna-Bertos E; Ramos-Torrecillas J; Vallecillo-Capilla MF; Ruiz C
J Oral Maxillofac Surg; 2012 Jul; 70(7):1558-64. PubMed ID: 21864971
[TBL] [Abstract][Full Text] [Related]
7. [HLA phenotype in patients with osteosarcoma].
Shimizu T
Nihon Seikeigeka Gakkai Zasshi; 1989 Apr; 63(4):269-73. PubMed ID: 2738427
[TBL] [Abstract][Full Text] [Related]
8. TMMR-2, a monoclonal antibody to human osteosarcoma.
McGuire MH; Ritter RA; Roodman ST; Tsai CC
Chir Organi Mov; 1990; 75(1 Suppl):5. PubMed ID: 2249557
[No Abstract] [Full Text] [Related]
9. Characterization of osteosarcoma cell lines MG-63, Saos-2 and U-2 OS in comparison to human osteoblasts.
Pautke C; Schieker M; Tischer T; Kolk A; Neth P; Mutschler W; Milz S
Anticancer Res; 2004; 24(6):3743-8. PubMed ID: 15736406
[TBL] [Abstract][Full Text] [Related]
10. In vitro characterization of immune-related properties of human fetal bone cells for potential tissue engineering applications.
Montjovent MO; Bocelli-Tyndall C; Scaletta C; Scherberich A; Mark S; Martin I; Applegate LA; Pioletti DP
Tissue Eng Part A; 2009 Jul; 15(7):1523-32. PubMed ID: 19196143
[TBL] [Abstract][Full Text] [Related]
11. Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications for immune recognition.
Berghuis D; de Hooge AS; Santos SJ; Horst D; Wiertz EJ; van Eggermond MC; van den Elsen PJ; Taminiau AH; Ottaviano L; Schaefer KL; Dirksen U; Hooijberg E; Mulder A; Melief CJ; Egeler RM; Schilham MW; Jordanova ES; Hogendoorn PC; Lankester AC
J Pathol; 2009 Jun; 218(2):222-31. PubMed ID: 19274709
[TBL] [Abstract][Full Text] [Related]
12. Bone biology and physiology: implications for novel osteoblastic osteosarcoma treatments?
Spangler JG
Med Hypotheses; 2008; 70(2):281-6. PubMed ID: 17683874
[TBL] [Abstract][Full Text] [Related]
13. Uptake, penetration, and binding of monoclonal antibodies with increasing affinity in human osteosarcoma multicell spheroids.
Hjelstuen MH; Rasch-Halvorsen K; Bruland O; De L Davies C
Anticancer Res; 1998; 18(5A):3153-61. PubMed ID: 9858878
[TBL] [Abstract][Full Text] [Related]
14. HLA phenotypes in patients who have osteosarcoma.
Shimizu T; Chigira M; Nagase M; Watanabe H; Udagawa E
J Bone Joint Surg Am; 1990 Jan; 72(1):68-70. PubMed ID: 2295675
[TBL] [Abstract][Full Text] [Related]
15. Effect of acetaminophen (paracetamol) on human osteosarcoma cell line MG63.
Díaz-Rodríguez L; García-Martínez O; Arroyo-Morales M; Rubio-Ruiz B; Ruiz C
Acta Pharmacol Sin; 2010 Nov; 31(11):1495-9. PubMed ID: 21052086
[TBL] [Abstract][Full Text] [Related]
16. Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples.
He C; Xiong J; Xu X; Lu W; Liu L; Xiao D; Wang D
Biochem Biophys Res Commun; 2009 Oct; 388(1):35-40. PubMed ID: 19632201
[TBL] [Abstract][Full Text] [Related]
17. Recognition by cellular and humoral autologous immunity in a human osteosarcoma cell line.
Nabeta Y; Kawaguchi S; Sahara H; Ikeda H; Hirohashi Y; Goroku T; Sato Y; Tsukahara T; Torigoe T; Wada T; Kaya M; Hiraga H; Isu K; Yamawaki S; Ishii S; Yamashita T; Sato N
J Orthop Sci; 2003; 8(4):554-9. PubMed ID: 12898310
[TBL] [Abstract][Full Text] [Related]
18. Isolation and partial purification of plasma membrane-associated antigens from human osteosarcoma (TE-85) cells in tissue culture.
Singh I; Tsang KY; Blakemore WS
Cancer Res; 1976 Nov; 36(11 Pt 1):4130-6. PubMed ID: 824049
[TBL] [Abstract][Full Text] [Related]
19. Evidence for animal origin of cells and rescued tumour virus from a putative human osteosarcoma cell line.
Hlozánek I; Altaner C; Donner L; Kucerová M; Mach O; Machala O; Sainerová H; Sovová V; Svoboda J
Folia Biol (Praha); 1975; 21(6):400-5. PubMed ID: 54267
[TBL] [Abstract][Full Text] [Related]
20. [Humoral immunity in human sarcomas].
Sergeev SI; Bergol'ts VM; Kovalev BN; Timofeevskaia EA
Vopr Onkol; 1976; 22(8):17-21. PubMed ID: 1069401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
